Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology
Clinical Trials: Mesothelioma
A listing of clinical trials currently looking for volunteers to enroll in Mesothelioma studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : University of Alabama at Birmingham
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)
California
Corona : Wilshire Oncology Medical Group
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Duarte : City of Hope-Comprehensive Cancer Cente
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Florida
Tampa : H. Lee Moffitt Cancer Center
CRS-207 Cancer Vaccine in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Illinois
Elgin : Sherman Health
SWOG S0905 Phase I/II Randomized Study of Pemetrexed Disodium and Cisplatin With Versus Without Cediranib Maleate in Patients With Malignant Pleural Mesothelioma
View More »
Chicago : University of Chicago
An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
Maryland
Baltimore : Johns Hopkins
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Bethesda : National Cacner Institue
A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers
Bethesda : National Cancer Institute
CRS-207 Cancer Vaccine in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
New Jersey
Basking Ridge : Memorial Sloan-Kettering at Basking Ridge
Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy
New York
Commack : Memorial Sloan-Kettering Cancer Center @ Suffolk
Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy
New York : New York University Cancer Center
An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
New York : Columbia University
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
New York : Memorial Sloan-Kettering Cancer Center
Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy
Rockville Centre : Memorial Sloan-Kettering at Mercy Medical Center
Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy
View More »
Sleepy Hollow : Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center
Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy
Oklahoma
Tennessee
Texas
Dallas : UTsouthwestern medical center
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Houston : Md Anderson Cancer Center
Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy
Belgium
Antwerpen : UZ Antwerpen
A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.
Bruxelles : Cliniques Universitarie St. Luc
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Bruxelles : Institut Jules Bordet
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Gent : Universitair Ziekenhuis
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Ghent : University Hospital Ghent
A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.
View More »
Liège : Centre Hospitalier Universitaire de Liège
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Mechelen : AZ St. Maarten
A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.
Canada
Edmonton : UAB - Alberta Cancer Board - Cross Cancer Institute
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Toronto : University Health Network, Princess Margaret Hospital
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Toronto : University Health Network
Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
Egypt
Cairo : National Cancer Institute
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Ireland
Dublin : St James's Hospital
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Italy
Alessandria : Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Alessandria : Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma
Aviano : Centro di Riferimento Oncologico
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Como : Ospedale Valduce
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Genoa : Istituto Nazionale per la Ricerca sul Cancro
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
View More »
Genova : Asl 3 genovese, Ospedale Villa Scassi
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma
Milan : Fondazione San Raffaele del Monte Tabor
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Monferrato : Ospedale Santo Spirito
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Monza : Azienda Ospedaliera San Gerardo
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Orbassano : Azienda Ospedaliera Universitaria San Luigi Gonzaga
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Padova : Istituto Oncologico Veneto
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Parma : Azienda Ospedaliero Universitaria di Parma
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Pavia : IRCCS Policlinico S. Matteo
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma
Rho : A.O. Salvini Garbagnate, Ospedale di Rho
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Rozzano : Istituto Clinico Humanitas
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma
Siena : Azienda Ospedaliera Senese
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Siena : Medical Oncology and Immunotherapy Unit, University Hospital of Siena
The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma
Treviso : Ospedale Ca' Foncello
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma
Netherlands
Amsterdam : Antoni van Leeuwenhoekziekenhuis (NKI-AVL)
Axitinib in Malignant Mesothelioma
Harderwijk : St. Jansdal Hospital
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Heerlen : AMC Heerlen
A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.
Nieuwegein : St. Antonius Hospital
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Poland
Gdansk : Medical University of Gdansk
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Warsaw : Maria Sklodowska Memorial Cancer Center and Institute of Oncology
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
United Kingdom
Cottingham : Castle Hill Hospital
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Glasgow : The Beatson West of Scotland Cancer Centre
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Leicester : University Hospitals of Leicester
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
London : Guy's Hospital
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
London : The Royal Marsden Hospital
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
View More »
Maidstone : Kent Oncology Centre Maidstone Hospital
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Manchester : Chest Clinic, Wythenshawe Hospital
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Middlesex : Mount Vernon Cancer Centre
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Sheffield : Weston Park Hospital, Sheffield Teaching Hospitals NHS Foundation Trust
Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.
Sutton : The Royal Marsden Hospital
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
